Le Lézard
Classified in: Health, Science and technology

WCG FDAnews Announces: Gene & Cell Therapy Regulation Webinar on December 14, 2022


For drug makers involved in developing gene and cell therapy products, the FDA and other regulators have made it clear: comparability studies are essential to product approval. It is critical that drug makers understand these new requirements in order to avoid minor process changes that could result in quality, efficacy or compliance challenges.

FALLS CHURCH, Va., Dec. 1, 2022 /PRNewswire-PRWeb/ -- This webinar will enable attendees to understand and comply with the FDA's cell and gene therapy requirements and avoid common errors that can result in quality, efficacy, or compliance challenges. It is critical for drug makers maintain their products' critical quality attributes (CQAs) and bring them to market.

Scott R. Burger, MD, the principal of Advanced Cell & Gene Therapy, and William E. Janssen, PhD, the principal of WEJ Cell and Gene Therapy Consulting Services, will explain exactly what attendees need to know about comparability, including:

Webinar Details
Gene & Cell Therapy Regulation:
Comparability and Other New Developments
An FDAnews Webinar
Wednesday, December 14, 2022, 1:30 p.m.?3:00 p.m. EST
https://wcg.swoogo.com/gene-t-cell-therapy-regulation

Tuition:
$287

Easy Ways to Order:
Online: https://wcg.swoogo.com/gene-t-cell-therapy-regulation
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews' newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations. Learn more at fdanews.com.

Media Contact

Michelle Butler, FDAnews, 703.538.7665, [email protected]

 

SOURCE FDAnews


These press releases may also interest you

at 13:36
Canadian Blood Services is hosting a three-day pop-up barber shop event to raise awareness about the need for stem cell donors and help interested individuals register to become stem cell donors. The event will encourage young males between the ages...

at 13:27
Quest Diagnostics , the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2023 for the ninth consecutive year. ...

at 13:20
MedSpa Partners Inc. ("MSP") is proud to welcome Dr. Shino Bay Aguilera and his team to its top-tier North American medical aesthetics platform. Based in Fort Lauderdale, Florida, Shino Bay Cosmetic Dermatology & Laser Institute has been providing...

at 13:17
A new double-blind, randomized, placebo?controlled study reveals a natural, safe and effective path for women who face hair thinning, a condition commonly experienced in menopause. The new study, conducted with menopausal women, found oral intake of...

at 13:05
Berkeley-based precision medicine solutions provider Newomics Inc. has announced the commercial placement of its 100th mass spectrometry front-end system, which has contributed to successful customer applications in the development of biotherapeutics...

at 13:00
The dermatology devices market size reached USD 5.46 Billion in 2021 and is expected to register a CAGR of 12.7% during the forecast period, according to latest analysis by Emergen Research. One key factor driving market revenue growth is rising...



News published on 1 december 2022 at 00:00 and distributed by: